GV 2017, L.P.

Insider CIK 1733340 · GTLB 10% owner · DBTX 10% owner · RCUS 10% owner · LIFE 10% owner · VERV 10% owner

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
LIFE Ethos Technologies Inc.	C Conversion deriv	2026-01-30	2026-01-30	3,287,925	—	$0	0	SEC↗
LIFE Ethos Technologies Inc.	C Conversion deriv	2026-01-30	2026-01-30	552,126	—	$0	0	SEC↗
LIFE Ethos Technologies Inc.	C Conversion deriv	2026-01-30	2026-01-30	1,751,791	—	$0	0	SEC↗
LIFE Ethos Technologies Inc.	C Conversion	2026-01-30	2026-01-30	1,755,632	—	$0	1,755,632	SEC↗
LIFE Ethos Technologies Inc.	S Sale	2026-01-30	2026-01-30	89,676	$19.00	$1.70M	3,198,249	SEC↗
LIFE Ethos Technologies Inc.	S Sale	2026-01-30	2026-01-30	1,755,632	$19.00	$33.36M	0	SEC↗
LIFE Ethos Technologies Inc.	C Conversion	2026-01-30	2026-01-30	571,907	—	$0	571,907	SEC↗
LIFE Ethos Technologies Inc.	C Conversion	2026-01-30	2026-01-30	3,287,925	—	$0	3,287,925	SEC↗
VERV Verve Therapeutics, Inc.	U Tender	2025-07-25	2025-07-28	1,800,000	—	$0	0	SEC↗
VERV Verve Therapeutics, Inc.	U Tender	2025-07-25	2025-07-28	4,260,047	—	$0	0	SEC↗
VERV Verve Therapeutics, Inc.	U Tender	2025-07-25	2025-07-28	6,108,442	—	$0	0	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-04	2022-11-08	651	$31.99	$20.8K	242	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-04	2022-11-08	243	$32.90	$8.0K	4,260,047	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-04	2022-11-08	650	$31.99	$20.8K	4,260,290	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-04	2022-11-08	47,690	$31.12	$1.48M	893	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-04	2022-11-08	242	$32.90	$8.0K	0	SEC↗
VERV Verve Therapeutics, Inc.	J Other	2022-11-04	2022-11-08	48,583	—	$0	6,108,442	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-04	2022-11-08	47,690	$31.12	$1.48M	4,260,940	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-03	2022-11-04	22,279	$32.32	$720.1K	4,335,919	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-03	2022-11-04	1,755	$33.84	$59.4K	0	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-03	2022-11-04	25,535	$33.14	$846.2K	1,755	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-03	2022-11-04	22,279	$32.32	$720.1K	27,290	SEC↗
VERV Verve Therapeutics, Inc.	J Other	2022-11-03	2022-11-04	49,569	—	$0	6,157,025	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-03	2022-11-04	25,534	$33.14	$846.2K	4,310,385	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-03	2022-11-04	1,755	$33.84	$59.4K	4,308,630	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-02	2022-11-04	8,930	$36.78	$328.4K	4,358,198	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-02	2022-11-04	10,372	$36.28	$376.3K	4,367,128	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-02	2022-11-04	9,350	$34.78	$325.2K	4,377,500	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-02	2022-11-04	8,930	$36.78	$328.4K	0	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-02	2022-11-04	10,372	$36.28	$376.3K	8,930	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-02	2022-11-04	9,349	$34.78	$325.2K	19,302	SEC↗
VERV Verve Therapeutics, Inc.	J Other	2022-11-02	2022-11-04	28,651	—	$0	6,206,594	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-01	2022-11-02	29,326	$36.69	$1.08M	4,389,487	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-01	2022-11-02	260	$38.64	$10.0K	0	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-01	2022-11-02	2,377	$37.82	$89.9K	260	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-01	2022-11-02	29,326	$36.69	$1.08M	2,637	SEC↗
VERV Verve Therapeutics, Inc.	J Other	2022-11-01	2022-11-02	31,963	—	$0	6,235,245	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-01	2022-11-02	2,377	$37.82	$89.9K	4,387,110	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-11-01	2022-11-02	260	$38.64	$10.0K	4,386,850	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-10-31	2022-11-02	88	$40.64	$3.6K	4,418,813	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-10-31	2022-11-02	6,601	$40.16	$265.1K	4,418,901	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-10-31	2022-11-02	23,275	$38.94	$906.3K	4,425,502	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-10-31	2022-11-02	23,732	$37.91	$899.7K	4,448,777	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-10-31	2022-11-02	88	$40.64	$3.6K	0	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-10-31	2022-11-02	6,601	$40.16	$265.1K	88	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-10-31	2022-11-02	23,276	$38.94	$906.4K	6,689	SEC↗
VERV Verve Therapeutics, Inc.	S Sale	2022-10-31	2022-11-02	23,732	$37.91	$899.7K	29,965	SEC↗
VERV Verve Therapeutics, Inc.	J Other	2022-10-31	2022-11-02	53,697	—	$0	6,267,208	SEC↗
GTLB Gitlab Inc.	C Conversion deriv	2021-10-18	2022-05-06	8,374,040	—	$0	0	SEC↗
GTLB Gitlab Inc.	C Conversion deriv	2021-10-18	2022-05-06	514,736	—	$0	0	SEC↗
GTLB Gitlab Inc.	C Conversion deriv	2021-10-18	2022-05-06	8,888,776	—	$0	8,888,776	SEC↗
VERV Verve Therapeutics, Inc.	C Conversion deriv	2021-06-21	2021-06-22	58,528,428	—	$0	0	SEC↗
VERV Verve Therapeutics, Inc.	C Conversion	2021-06-21	2021-06-22	6,320,905	—	$0	6,320,905	SEC↗
DBTX Decibel Therapeutics, Inc.	C Conversion deriv	2021-02-17	2021-02-17	6,250,000	—	$0	0	SEC↗
DBTX Decibel Therapeutics, Inc.	C Conversion	2021-02-17	2021-02-17	494,649	—	$0	494,649	SEC↗
RCUS Arcus Biosciences, Inc.	C Conversion deriv	2018-03-19	2018-03-19	1,924,474	—	$0	0	SEC↗
RCUS Arcus Biosciences, Inc.	C Conversion	2018-03-19	2018-03-19	1,924,474	—	$0	1,924,474	SEC↗